Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1338.HK Stock Summary
In the News
1338.HK Financial details
Company Rating
Buy
Market Cap
148.63M
Income
-9.66M
Revenue
503.88M
Book val./share
0.04
Cash/share
0.02
Dividend
-
Dividend %
-
Employees
211
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
-8.25
Forward P/E
-
PEG
-23.93
P/S
0.53
P/B
1.03
P/C
2.45
P/FCF
5.89
Quick Ratio
1.02
Current Ratio
1.31
Debt / Equity
0.22
LT Debt / Equity
0.16
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
110.34%
EPS next Y
-
EPS next 5Y
5332%
EPS last 5Y
72.45%
Revenue last 5Y
-3.47%
Revenue Q/Q
-23.85%
EPS Q/Q
-240%
-
-
-
-
SMA20
-
SMA50
25%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-6%
ROE
-12%
ROC
-0.14%
Gross Margin
38%
Oper. Margin
-9%
Profit Margin
-6%
Payout
-
Shs Outstand
3.16B
Shs Float
3.16B
-
-
-
-
Target Price
-
52W Range
0.038-0.06
52W High
-
52W Low
-
RSI
55.91
Rel Volume
1.02
Avg Volume
221K
Volume
226K
Perf Week
8.89%
Perf Month
16.67%
Perf Quarter
6.52%
Perf Half Y
2.08%
-
-
-
-
Beta
0.566
-
-
Volatility
0%, 0%
Prev Close
4.26%
Price
0.049
Change
4.26%
1338.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.09 | 0.08 | 0.09 | 0.09 | 0.08 | |
Net income per share | 0 | 0 | 0 | 0 | -0.01 | |
Operating cash flow per share | 0 | 0.01 | 0.01 | 0 | 0.01 | |
Free cash flow per share | 0 | 0.01 | 0.01 | 0 | 0.01 | |
Cash per share | 0.03 | 0.03 | 0.04 | 0.02 | 0.02 | |
Book value per share | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | |
Tangible book value per share | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | |
Share holders equity per share | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | |
Interest debt per share | 0 | 0.01 | 0 | 0.02 | 0.01 | |
Market cap | 485.54M | 282.36M | 290.06M | 242.62M | 145.22M | |
Enterprise value | 432.6M | 197.15M | 179.2M | 236.8M | 104.1M | |
P/E ratio | -405.97 | -46.29 | -71.83 | -26.71 | -7.47 | |
Price to sales ratio | 1.65 | 1.09 | 1.05 | 0.89 | 0.59 | |
POCF ratio | 64.33 | 10.28 | 7.65 | 151.73 | 6.02 | |
PFCF ratio | 92.34 | 12.15 | 8.31 | -3.73K | 6.56 | |
P/B Ratio | 2.93 | 1.78 | 1.87 | 1.66 | 1.15 | |
PTB ratio | 2.93 | 1.78 | 1.87 | 1.66 | 1.15 | |
EV to sales | 1.47 | 0.76 | 0.65 | 0.87 | 0.42 | |
Enterprise value over EBITDA | 23.36 | 27.08 | 10 | 29.42 | 52.31 | |
EV to operating cash flow | 57.32 | 7.18 | 4.73 | 148.09 | 4.32 | |
EV to free cash flow | 82.28 | 8.48 | 5.13 | -3.64K | 4.7 | |
Earnings yield | 0 | -0.02 | -0.01 | -0.04 | -0.13 | |
Free cash flow yield | 0.01 | 0.08 | 0.12 | 0 | 0.15 | |
Debt to equity | 0.08 | 0.26 | 0.07 | 0.37 | 0.26 | |
Debt to assets | 0.04 | 0.14 | 0.04 | 0.18 | 0.14 | |
Net debt to EBITDA | -2.86 | -11.71 | -6.19 | -0.72 | -20.67 | |
Current ratio | 1.43 | 1.5 | 1.6 | 1.24 | 1.31 | |
Interest coverage | -3.37 | -5.92 | -3.6 | -8.37 | -9.5 | |
Income quality | -6.31 | -4.5 | -9.38 | -0.18 | -1.24 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.09 | 0.12 | 0.1 | 0.11 | 0.13 | |
Research and developement to revenue | 0.04 | 0.06 | 0.05 | 0.05 | 0.06 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.3 | -0.15 | -0.08 | -1.04 | -0.08 | |
Capex to revenue | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -0.12 | -0.15 | -0.1 | -0.05 | -0.06 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.02 | 0.05 | 0.04 | 0.05 | 0.07 | |
ROIC | -0.01 | -0.1 | -0.03 | -0.05 | -0.1 | |
Return on tangible assets | 0 | -0.02 | -0.02 | -0.03 | -0.08 | |
Graham Net | 0 | 0 | 0.01 | -0.02 | -0.01 | |
Working capital | 50.66M | 53.73M | 65.5M | 25.02M | 29.31M | |
Tangible asset value | 165.68M | 158.66M | 154.73M | 145.86M | 126.02M | |
Net current asset value | 50.66M | 29.93M | 65.17M | -18.29M | 4.2M | |
Invested capital | 0.08 | 0.26 | 0.07 | 0.37 | 0.26 | |
Average receivables | 38.22M | 28.77M | 22.37M | 21.04M | 17.13M | |
Average payables | 31.99M | 32.35M | 33.89M | 38.95M | 39.21M | |
Average inventory | 45.85M | 36.99M | 29.74M | 36.26M | 36.73M | |
Days sales outstanding | 43.36 | 31.99 | 29.24 | 26.64 | 21.16 | |
Days payables outstanding | 74.9 | 83.15 | 76.49 | 89.31 | 84.74 | |
Days of inventory on hand | 99.16 | 80.29 | 60.85 | 93.11 | 68.62 | |
Receivables turnover | 8.42 | 11.41 | 12.48 | 13.7 | 17.25 | |
Payables turnover | 4.87 | 4.39 | 4.77 | 4.09 | 4.31 | |
Inventory turnover | 3.68 | 4.55 | 6 | 3.92 | 5.32 | |
ROE | -0.01 | -0.04 | -0.03 | -0.06 | -0.15 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.04 | 0.05 | 0.04 | 0.04 | 0.03 | |
Net income per share | 0 | 0 | -0.01 | 0 | 0 | |
Operating cash flow per share | 0 | 0.01 | 0 | 0.01 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0.01 | 0 | |
Cash per share | 0.03 | 0.02 | 0.01 | 0.02 | 0.02 | |
Book value per share | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | |
Tangible book value per share | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 | |
Share holders equity per share | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | |
Interest debt per share | 0 | 0.02 | 0.02 | 0.01 | 0.01 | |
Market cap | 279.1M | 242.62M | 170.05M | 142.65M | 152.2M | |
Enterprise value | 183.17M | 236.8M | 174.78M | 101.52M | 123.85M | |
P/E ratio | -4.87 | 11.54 | -2.63 | -11 | 8.42 | |
Price to sales ratio | 2.41 | 1.54 | 1.47 | 1.09 | 1.53 | |
POCF ratio | -18.59 | 14.6 | -14.03 | 3.94 | -11.33 | |
PFCF ratio | -18.16 | 15.86 | -12.98 | 4.05 | -11.17 | |
P/B Ratio | 2 | 1.66 | 1.32 | 1.13 | 1.16 | |
PTB ratio | 2 | 1.66 | 1.32 | 1.13 | 1.16 | |
EV to sales | 1.58 | 1.5 | 1.51 | 0.78 | 1.24 | |
Enterprise value over EBITDA | -37.71 | 18.35 | -28.97 | 12.65 | 11.63 | |
EV to operating cash flow | -12.2 | 14.25 | -14.42 | 2.8 | -9.22 | |
EV to free cash flow | -11.92 | 15.48 | -13.34 | 2.88 | -9.09 | |
Earnings yield | -0.05 | 0.02 | -0.1 | -0.02 | 0.03 | |
Free cash flow yield | -0.06 | 0.06 | -0.08 | 0.25 | -0.09 | |
Debt to equity | 0.04 | 0.37 | 0.38 | 0.26 | 0.22 | |
Debt to assets | 0.02 | 0.18 | 0.19 | 0.14 | 0.14 | |
Net debt to EBITDA | 19.75 | -0.45 | -0.78 | -5.13 | -2.66 | |
Current ratio | 1.75 | 1.24 | 1.21 | 1.31 | 1.67 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 1.05 | 3.16 | 0.75 | -11.17 | -2.97 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.12 | 0.1 | 0.12 | 0.14 | 0.1 | |
Research and developement to revenue | 0 | 0.1 | 0 | 0.11 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.02 | -0.08 | 0.08 | -0.03 | 0.02 | |
Capex to revenue | 0 | -0.01 | -0.01 | -0.01 | 0 | |
Capex to depreciation | -0.02 | -0.08 | -0.07 | -0.06 | -0.02 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.07 | 0.04 | 0.07 | 0.03 | 0.04 | |
ROIC | -0.1 | 0.01 | -0.07 | -0.02 | 0.02 | |
Return on tangible assets | -0.06 | 0.02 | -0.06 | -0.01 | 0.02 | |
Graham Net | 0.01 | -0.02 | 0 | -0.01 | 0 | |
Working capital | 65.67M | 25.02M | 17.65M | 29.31M | 40.49M | |
Tangible asset value | 139.61M | 145.86M | 167.22M | 126.02M | 131.11M | |
Net current asset value | 65.35M | -18.29M | 17.65M | 4.2M | 19.61M | |
Invested capital | 0.04 | 0.37 | 0.38 | 0.26 | 0.22 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 13.29 | 11.38 | 15.74 | 9.83 | 12.72 | |
Days payables outstanding | 33.22 | 38.88 | 24.51 | 41.02 | 20.81 | |
Days of inventory on hand | 37.89 | 40.53 | 42.41 | 33.22 | 39.31 | |
Receivables turnover | 6.77 | 7.91 | 5.72 | 9.16 | 7.07 | |
Payables turnover | 2.71 | 2.31 | 3.67 | 2.19 | 4.32 | |
Inventory turnover | 2.38 | 2.22 | 2.12 | 2.71 | 2.29 | |
ROE | -0.1 | 0.04 | -0.13 | -0.03 | 0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
1338.HK Frequently Asked Questions
What is BaWang International (Group) Holding Limited stock symbol ?
BaWang International (Group) Holding Limited is a CN stock and trading under the symbol 1338.HK
What is BaWang International (Group) Holding Limited stock quote today ?
BaWang International (Group) Holding Limited stock price is $0.049 today.
Is BaWang International (Group) Holding Limited stock public?
Yes, BaWang International (Group) Holding Limited is a publicly traded company.